
    
      This is an open-label, single-center, one-arm, safety, tolerability, and PK study in healthy
      male and female volunteers of Methylene Blue Injection, USP. Following an overnight fast,
      twelve healthy adult male and female volunteers will receive a single dose of study drug at a
      dose of 1 mg/kg solution per kg given intravenously over a period of 5 minutes followed by
      serial venous blood sampling at 0.042, 0.083, 0.167, 0.25, 0.5, 0.75, 1, 2, 3, 4, 6, 8, 10,
      16, 36, 48, and 72 hours postdose.
    
  